Brief: Insilico Medicine Cayman TopCo Receives FDA Fast Track Designation For ISM6331 In Advanced Mesothelioma
29/07/2026 02:23
BRIEF-Insilico Medicine Cayman TopCo Receives FDA Fast Track Designation For ISM6331 In Advanced Mesothelioma July 29 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:
RECEIVES FDA FAST TRACK DESIGNATION FOR ISM6331 IN ADVANCED MESOTHELIOMA
Further company coverage: 3696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7